XML 131 R11.htm IDEA: XBRL DOCUMENT v3.25.2
Revenue (Notes)
 3 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue REVENUE
Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $141 million, $139 million and $138 million at June 30, 2025, December 31, 2024 and June 30, 2024, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of one year to six years.

Contract Balances
Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.

Contract BalancesJune 30, 2025December 31, 2024June 30, 2024
(In millions)
Accounts and notes receivable - trade1
$7,358 $4,615 $6,388 
Contract assets - current2
$31 $30 $29 
Contract assets - noncurrent3
$77 $74 $71 
Deferred revenue - current$358 $3,287 $413 
Deferred revenue - noncurrent4
$118 $114 $110 
1.Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.
2.Included in other current assets in the interim Consolidated Balance Sheets.
3.Included in other assets in the interim Consolidated Balance Sheets.
4.Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue recognized during the six months ended June 30, 2025 and 2024 from amounts included in deferred revenue at the beginning of the period was $3,091 million and $3,150 million, respectively.
Disaggregation of Revenue
Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:
Three Months Ended June 30,Six Months Ended
June 30,
(In millions)2025202420252024
    Corn$2,961 $2,683 $5,030 $4,770 
    Soybean1,257 1,317 1,562 1,609 
    Other oilseeds186 186 409 431 
    Other133 145 243 272 
Seed4,537 4,331 7,244 7,082 
    Herbicides995 946 1,855 1,832 
    Insecticides436 415 772 788 
    Fungicides342 250 646 545 
    Biologicals97 90 181 172 
    Other49 80 175 185 
Crop Protection1,919 1,781 3,629 3,522 
Total$6,456 $6,112 $10,873 $10,604 

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:
SeedThree Months Ended June 30,Six Months Ended
June 30,
(In millions)2025202420252024
North America1
$3,954 $3,753 $5,551 $5,224 
EMEA2
282 251 1,108 1,169 
Latin America154 207 339 478 
Asia Pacific147 120 246 211 
Total$4,537 $4,331 $7,244 $7,082 

Crop ProtectionThree Months Ended June 30,Six Months Ended
June 30,
(In millions)2025202420252024
North America1
$675 $647 $1,288 $1,263 
EMEA2
465 422 1,116 1,092 
Latin America518 443 775 687 
Asia Pacific261 269 450 480 
Total$1,919 $1,781 $3,629 $3,522 
1.Represents U.S. & Canada.
2.Europe, Middle East and Africa ("EMEA").